Inhibitors support immune therapy for leukemia
New immune therapies are considered a promising lead for treating recurring acute myeloid leukemia (AML). Antibodies are able to eliminate ...
New immune therapies are considered a promising lead for treating recurring acute myeloid leukemia (AML). Antibodies are able to eliminate ...
ARLINGTON, Va., Sept. 12, 2017 - The press program for the 2017 Annual Meeting of the American Society for Radiation ...
Madrid, September 12th, 2017.- PharmaMar (MSE:PHM) has presented today during the European Society for Medical Oncology congress (ESMO), held in ...
LUGANO-MADRID, 12 September, 2017 - ESMO 2017 was a truly global event with nearly 24,000 participants from 131 countries. The ...
Credit: Insilico Medicine,Inc. Tuesday, September 12th, 2017, Basel, Switzerland - Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specializing in ...
Credit: Kim Fleischer Michaelsen Researchers from the University of Copenhagen and humanitarian organizations have conducted a large study in Burkina ...
ANN ARBOR, Mich. ¬- What's worse than getting exposed to a kind of bacteria that modern antibiotics can't kill? Getting ...
LUGANO-MADRID, 9 September, 2017 - Osimertinib improves progression-free survival by 54% compared to standard first line therapy in patients with ...
Milan, 11 September 2017 - The names of the 2017 Balzan Prizewinners were disclosed today in a public announcement: Aleida ...
LUGANO-MADRID, 11 September, 2017 - Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage ...
LUGANO-MADRID, 10 September, 2017 - Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who ...
LUGANO-MADRID, 10 September, 2017 - Mature results from the KEYNOTE-045 trial to be presented today at the ESMO 2017 Congress ...
Credit: Osaka University (Osaka, Japan) While you are what you eat, cells are what they touch. The cells with which ...
STAMFORD, Conn. & NEW YORK, NY -- September 11, 2017 -- Scientists at the Icahn School of Medicine at Mount ...
Credit: Claire Benjamin/University of Illinois A Boeing 747 burns one gallon of jet fuel each second. A recent analysis from ...
Credit: (Purdue University image/Erin Easterling) WEST LAFAYETTE, Ind. - A consortium of experts is working to modernize a process that ...
Credit: Tom Maniatis/Columbia University's Zuckerman Institute NEW YORK -- Columbia scientists have discovered that one of the body's natural defenses ...
Credit: Jonathan Hillenbrand Aliso Viejo, CA and Evanston, IL (September 12, 2017): Ambry Genetics (Ambry), a leading clinical genetics-testing lab, ...
LUGANO-MADRID, 9 September 2017 - Factors that limit the work ability of young adult cancer survivors are reported today at ...
LUGANO-MADRID, 8 September, 2017 - Rucaparib maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer by 77%, according ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.